C4d as a diagnostic tool in proliferative GN

Journal of the American Society of Nephrology

Volumn 26, Issue 11, 2015, Pages 2852-2859

  Sethi, Sanjeev ^a   Nasr, Samih H ^a   De Vriese, An S ^b   Fervenza, Fernando C ^a  

^a MAYO CLINIC   (United States)

^b Department of Internal Medicine   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4D; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; ANTIGEN ANTIBODY COMPLEX; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; IMMUNOGLOBULIN; PEPTIDE FRAGMENT;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CLINICAL ARTICLE; COMPLEMENT MEDIATED GLOMERULOPATHY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNE COMPLEX MEDIATED GLOMERULOPATHY; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; POSTINFECTIOUS GLOMERULOPATHY; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; SCLEROSING MEMBRANOPROLIFERATIVE GLOMERULOPATHY; SIGNAL TRANSDUCTION; STAINING; BIOPSY; BLOOD; CHEMISTRY; FLUORESCENCE MICROSCOPY; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULUS; IMMUNOLOGY; KIDNEY; PATHOLOGY;

ANTIGEN-ANTIBODY COMPLEX; BIOPSY; COMPLEMENT C3; COMPLEMENT C4B; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNOGLOBULINS; KIDNEY; KIDNEY GLOMERULUS; MICROSCOPY, FLUORESCENCE; PEPTIDE FRAGMENTS;

EID: 84946046875     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014040406     Document Type: Article

References (33)

1. Sethi S, Fervenza FC: Membranoproliferative glomerulonephritis: Pathogenetic heterogeneity and proposal for a new classification. SeminNephrol 31: 341-348, 2011
2. Sethi S, Fervenza FC: Membranoproliferative glomerulonephritis a new look at an old entity. N Engl JMed 366: 1119-1131, 2012
3. Sethi S. Etiology-based diagnostic approach to proliferative glomerulonephritis. Am J Kidney Dis 63: 561-566, 2014
4. Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F: Primary glomerulonephritis with isolated C3 deposits: A new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet 44: 193-199, 2007
5. Sethi S, Fervenza FC, Zhang Y, Nasr SH, Leung N, Vrana J, Cramer C, Nester CM, Smith RJ: Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement. Clin J Am Soc Nephrol 6: 1009-1017, 2011
6. Sethi S, Fervenza FC, Zhang Y, Zand L, Vrana JA, Nasr SH, Theis JD, Dogan A, Smith RJ: C3 glomerulonephritis: Clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up. Kidney Int 82: 465-473, 2012
7. Gale DP, de Jorge EG, Cook HT, Martinez-Barricarte R, Hadjisavvas A, McLean AG, Pusey CD, Pierides A, Kyriacou K, Athanasiou Y, Voskarides K, Deltas C, Palmer A, Frémeaux-Bacchi V, de Cordoba SR, Maxwell PH, Pickering MC: Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 376: 794-801, 2010
8. Pickering MC, D'Agati VD, Nester CM, Smith RJ, Haas M, Appel GB, Alpers CE, Bajema IM, Bedrosian C, Braun M, Doyle M, Fakhouri F, Fervenza FC, Fogo AB, Frémeaux-Bacchi V, Gale DP, Goicoechea de Jorge E, Griffin G, Harris CL, Holers VM, Johnson S, Lavin PJ,Medjeral Thomas N, PaulMorgan B, Nast CC, Noel LH, Peters DK, Rodríguez de Córdoba S, Servais A, Sethi S, Song WC, Tamburini P, Thurman JM, Zavros M, Cook HT: C3 glomerulopathy: Consensus report. Kidney Int 84: 1079-1089, 2013
9. Larsen CP, Walker PD: Redefining C3 glomerulopathy: 'C3 only' is a bridge too far. Kidney Int 83: 331-332, 2013
10. Hou J, Markowitz GS, Bomback AS, Appel GB, Herlitz LC, Barry Stokes M, D'Agati VD: Toward a working definition of C3 glomerulopathy by immunofluorescence. Kidney Int 85: 450-456, 2014
11. EspinosaM, Ortega R, SánchezM, Segarra A, SalcedoMT, González F, Camacho R, Valdivia MA, Cabrera R, López K, Pinedo F, Gutierrez E, Valera A, Leon M, Cobo MA, Rodriguez R, Ballarín J, Arce Y, García B, Muñoz MD, Praga M; Spanish Group for Study of Glomerular Diseases (GLOSEN): Association of C4d deposition with clinical outcomes in IgA nephropathy. Clin J Am Soc Nephrol 9: 897-904, 2014
12. Sethi S, Sullivan A, Smith RJ: C4 dense-deposit disease. N Engl J Med 370: 784-786, 2014
13. Ohsawa I, Ohi H, Endo M, Fujita T, Matsushita M, Fujita T: Evidence of lectin complement pathway activation in poststreptococcal glomerulonephritis. Kidney Int 56: 1158-1159, 1999
14. Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Williams WW, Tolkoff-RubinN,Cosimi AB,Colvin RB: Complement activation in acute humoral renal allograft rejection: Diagnostic significance of C4d deposits in peritubular capillaries.JAmSocNephrol 10: 2208-2214, 1999
15. Cohen D, Colvin RB, Daha MR, Drachenberg CB, Haas M, Nickeleit V, Salmon JE, Sis B, ZhaoMH, Bruijn JA, Bajema IM: Pros and cons for C4d as a biomarker. Kidney Int 81: 628-639, 2012
16. Batal I, Chalasani G, Wu C, Shapiro R, Bastacky S, Randhawa P: Deposition of complement product C4d in anti-glomerular basement membrane glomerulonephritis. AmJ Kidney Dis 53: 1098-1101, 2009
17. Batal I, Liang K, Bastacky S, Kiss LP, McHale T, Wilson NL, Paul B, Lertratanakul A, Ahearn JM, Manzi SM, Kao AH: Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: A pilot study. Lupus 21: 13-26, 2012
18. Kusunoki Y, Itami N, Tochimaru H, Takekoshi Y, Nagasawa S, Yoshiki T: Glomerular deposition of C4 cleavage fragment (C4d) and C4-binding protein in idiopathic membranous glomerulonephritis. Nephron 51: 17-19, 1989
19. Rodriguez EF, Cosio FG, Nasr SH, Sethi S, Fidler ME, Stegall MD, Grande JP, Fervenza FC, Cornell LD: The pathology and clinical features of early recurrent membranous glomerulonephritis. Am J Transplant 12: 1029-1038, 2012
20. Dhir V: Is cellular C4d a good biomarker for SLE nephritis? Lupus 21: 1036, 2012
21. XingGQ,ChenM,LiuG, Zheng X,E J, ZhaoMH: Differential depositionof C4d andMBL in glomeruli of patients withANCA-negative pauci-immune crescentic glomerulonephritis. J Clin Immunol 30: 144-156, 2010
22. Kim MK, Maeng YI, Lee SJ, Lee IH, Bae J, Kang YN, Park BT, Park KK: Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: Activation of classical and lectin pathways. Int J Clin Exp Pathol 6: 2157-2167, 2013
23. Sethi S, Fervenza FC, Zhang Y, Zand L, Meyer NC, Borsa N, Nasr SH, Smith RJ: Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement. Kidney Int 83: 293-299, 2013
24. Montseny JJ,Meyrier A, Kleinknecht D, Callard P: The current spectrum of infectious glomerulonephritis. Experience with 76 patients and review of the literature. Medicine (Baltimore) 74: 63-73, 1995
25. Nadasdy T, Hebert LA: Infection-related glomerulonephritis: Understanding mechanisms. Semin Nephrol 31: 369-375, 2011
26. Nasr SH, Fidler ME, Valeri AM, Cornell LD, Sethi S, Zoller A, StokesMB, Markowitz GS, D'Agati VD: Postinfectious glomerulonephritis in the elderly. J Am Soc Nephrol 22: 187-195, 2011
27. Nicolas C, Vuiblet V, Baudouin V, Macher MA, Vrillon I, Biebuyck Gouge N, Dehennault M, Gié S, Morin D, Nivet H, Nobili F, Ulinski T, Ranchin B,MarinozziMC, Ngo S, Frémeaux-Bacchi V, Pietrement C: C3 nephritic factor associated with C3 glomerulopathy in children. Pediatr Nephrol 29: 85-94, 2014
28. Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, Stokes MB, Nadasdy T, D'Agati VD: Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 20: 2055-2064, 2009
29. Nasr SH, Markowitz GS, Stokes MB, Said SM, Valeri AM, D'Agati VD: Acute postinfectious glomerulonephritis in the modern era: Experience with 86 adults and review of the literature.Medicine (Baltimore) 87: 21 32, 2008
30. Zand L, Kattah A, Fervenza FC, Smith RJ, Nasr SH, Zhang Y, Vrana JA, Leung N, Cornell LD, Sethi S: C3 glomerulonephritis associated with monoclonal gammopathy: A case series. AmJ Kidney Dis 62: 506-514, 2013
31. Larsen CP, Ambuzs JM, Bonsib SM, Boils CL, Nicholas Cossey L, Messias NC, Silva FG,Wang YH, Gokden N, Walker PD: Membranouslike glomerulopathy with masked IgG kappa deposits. Kidney Int 86: 154-161, 2014
32. Nasr SH, Galgano SJ, Markowitz GS, Stokes MB, D'Agati VD: Immunofluorescence on pronase-digested paraffin sections: A valuable salvage technique for renal biopsies. Kidney Int 70: 2148-2151, 2006
33. Sethi S, Vrana JA, Theis JD, Dogan A: Mass spectrometry based proteomics in the diagnosis of kidney disease. Curr Opin Nephrol Hypertens 22: 273-280, 2013